Cardiac monitoring and cardiac rhythm management devices play a crucial role in diagnosing, monitoring, and treating various cardiac conditions. These devices are designed to monitor the electrical activity of the heart, detect irregularities, and deliver therapeutic interventions to manage cardiac rhythm disorders.
Latest Cardiac Monitoring and Cardiac Rhythm Management Device Companies Updates:
Medtronic announces FDA approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemaker, offering improved functionality and longevity
Abbott receives CE Mark approval for its Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, featuring smartphone connectivity and integrated applications for enhanced patient engagement and remote monitoring in Europe.
Boston Scientific expands its electrophysiology portfolio with the acquisition of Rhythmia, a company developing innovative ablation platforms for treating arrhythmias.The Heart Rhythm Society (HRS) collaborates with industry stakeholders to develop and update clinical guidelines for cardiac rhythm management and promote best practices.
List of Cardiac Monitoring and Cardiac Rhythm Management Device Key companies in the market:
Cardiac Monitoring advance technologies global Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)